Evidence map›Paper›PMID 38951616›Full record

ArticleNature chemistry2024

Diastereodivergent nucleophile-nucleophile alkene chlorofluorination.

Sayad Doobary, Andrew J D Lacey, Stephen G Sweeting, Sarah B Coppock, Henry P Caldora, Darren L Poole, Alastair J J Lennox

Abstract read
In one paragraph

Article in Nature chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Fluorination of amino-quinones enhances anti-RSC medicinal chemistry · 2026
    Article
  2. Article
  3. Article
  4. Enriching AlkeneOrganic letters · 2026
    Article
  5. Non-Aqueous Binary and TernaryJournal of the American Chemical Society · 2025
    Article
  6. Article
  7. General Alkene 1,2-Journal of the American Chemical Society · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sayad Doobary *University of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0002-6402-1391
Andrew J D Lacey *University of Bristol, Bristol, UK.
Stephen G SweetingUniversity of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0002-1966-9156
Sarah B CoppockUniversity of Bristol, Bristol, UK.
Henry P CaldoraUniversity of Bristol, Bristol, UK.ORCID http://orcid.org/0000-0001-8020-1731
Darren L PooleDiscovery High-Throughput Chemistry, Medicinal Chemistry, GSK Medicines Research Centre, Stevenage, UK.ORCID http://orcid.org/0000-0001-5050-5996
Alastair J J LennoxUniversity of Bristol, Bristol, UK. a.lennox@bristol.ac.uk.ORCID http://orcid.org/0000-0003-2019-7421

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 949821RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/L015366/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/S018050/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/S024107/1Royal Society Enhancement awardsRoyal Society University Research Fellowship
6 · The paper itself

Abstract

The selective hetero-dihalogenation of alkenes provides useful building blocks for a broad range of chemical applications. Unlike homo-dihalogenation, selective hetero-dihalogenation reactions, especially fluorohalogenation, are underdeveloped. Current approaches combine an electrophilic halogen source with a nucleophilic halogen source, which necessarily leads to anti-addition, and regioselectivity has only been achieved using highly activated alkenes. Here we describe an alternative, nucleophile-nucleophile approach that adds chloride and fluoride ions over unactivated alkenes in a highly regio-, chemo- and diastereoselective manner. A curious switch in the reaction mechanism was discovered, which triggers a complete reversal of the diastereoselectivity to promote either anti- or syn-addition. The conditions are demonstrated on an array of pharmaceutically relevant compounds, and detailed mechanistic studies reveal the selectivity and the switch between the syn- and anti-diastereomers are based on different active iodanes and which of the two halides adds first.

Identifiers

PMID38951616
PMCPMC11446824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.